Postoperative Replacement of Intraoperative Iron Losses
Status:
Not yet recruiting
Trial end date:
2022-10-31
Target enrollment:
Participant gender:
Summary
By performing a randomized, blinded placebo controlled exploratory trial we speculate that
replacement of perioperative, bleeding-induced iron losses with ferric carboxymaltose
immediately after the surgical procedure can replenish iron with increased hemoglobin levels
and reduce the amount of pRBCs transfused in the postoperative period (30 days post surgery).